BioSpace News Archive

Business

Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025

Greenwich LifeSciences, Inc. announced that its Board of Directors has extended the lock-up of the shares owned by the Company’s directors, officers, and existing pre-IPO investors to June 30, 2025 which is approximately 57 months from date of the Company’s IPO.

March 13, 2024
·
4 min read
Lone Star Bio

Caris Life Sciences to Showcase Research at 2024 SGO Annual Meeting on Women’s Cancer

Caris Life Sciences®, announced that the company and collaborators within the Caris Precision Oncology Alliance™ will collectively present three studies across multiple gynecological tumor types at the 2024 SGO Annual Meeting on Women’s Cancer, March 16-18, 2024, in San Diego.

March 13, 2024
·
5 min read
Ricoh and ERS Genomics Enter into CRISPR/Cas9 License Agreement

Ricoh Company, Ltd. announced a non-exclusive licensing agreement in the USA and Japan with ERS Genomics Limited for access to the foundational CRISPR/Cas9 genome editing technology patents managed by ERS Genomics.

March 13, 2024
·
2 min read
Chief Financial Officer (CFO) Ole Larsen Buys Shares

FluoGuide A/S announces that Ole Larsen has bought shares.

March 13, 2024
·
1 min read
Business

Entrada Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

Entrada Therapeutics, Inc. is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible.

March 13, 2024
·
10 min read
FDA

Pacira BioSciences Announces PCRX-201 Granted Regenerative Medicine Advance Therapy (RMAT) Designation for the Treatment of Osteoarthritis of the Knee

Pacira BioSciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to PCRX-201.

March 13, 2024
·
8 min read
Genetown

Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer

Voyager Therapeutics, Inc. today announced the appointment of Toby Ferguson, M.D., Ph.D., as Chief Medical Officer (CMO), effective March 25, 2024.

March 13, 2024
·
5 min read
Biotech Bay

BioCardia and StemCardia Announce Biotherapeutic Delivery Partnership

BioCardia, Inc. and StemCardia, Inc. announced a long-term partnership to advance StemCardia’s investigational pluripotent stem cell product candidate for the treatment of heart failure.

March 13, 2024
·
4 min read
FDA

Ventris Medical Receives 510(k) Additional Clearance for Amplify® Standalone Bone Graft Putty

Ventris Medical today announced that the United States Food and Drug Administration has granted 510(k) clearance in the intervertebral disc space for Synthetic Bone Graft Putty (Amplify®).

March 13, 2024
·
3 min read
AB Science: New research shows that masitinib limits neuronal damage in a model of neuroimmune-driven neurodegenerative disease

AB Science SA announced the publication of new preclinical results for masitinib in neurodegenerative diseases.

March 13, 2024
·
7 min read